Related Experiment Videos
Impact of Tumor-Derived CCL2 on Macrophage Effector Function
Journal of Biomedicine & Biotechnology
|February 4, 2005
Summary
Tumor-derived monocyte chemoattractant protein-1 (MCP-1, CCL2) influences macrophage cytokine gene expression but not protein production or antitumor activity. This suggests CCL2 does not directly impact the innate immune response to cancer.
Area of Science:
- Immunology
- Oncology
- Cell Biology
Background:
- Monocyte chemoattractant protein-1 (MCP-1, CCL2) is a chemokine produced by various cells.
- Understanding the role of tumor-derived CCL2 in modulating the innate immune response to cancer is crucial.
Purpose of the Study:
- To evaluate the effect of tumor-derived CCL2 on macrophages.
- To determine how CCL2 influences the innate immune response in cancer.
Main Methods:
- Utilized 4T1 murine mammary carcinoma cell line, engineered to express antisense CCL2 transcript to abolish CCL2 production.
- Exposed BALB/c mouse macrophages to supernatants from both CCL2-expressing and non-expressing 4T1 cells.
Main Results:
- Tumor-derived CCL2 modulated cytokine gene expression in macrophages (resting, activated, and tumor-associated).
- CCL2 did not affect macrophage protein production, phagocytic activity, nitric oxide production, or cytolytic activity.
- No direct influence of tumor-derived CCL2 on macrophage-mediated antitumor activity was observed.
Conclusions:
- Tumor-derived CCL2 primarily affects cytokine gene expression rather than protein production in macrophages.
- CCL2 does not directly enhance or impair macrophage functions critical for antitumor responses.